Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Neoplasms of the CNS

  Free Subscription

Articles published in Brain

Retrieve available abstracts of 16 articles:
HTML format

Single Articles

    January 2020
  1. BONGAARTS A, van Scheppingen J, Korotkov A, Mijnsbergen C, et al
    The coding and non-coding transcriptional landscape of subependymal giant cell astrocytomas.
    Brain. 2020;143:131-149.
    PubMed     Abstract available

    December 2019
  2. HAN M, Wang S, Fritah S, Wang X, et al
    Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/beta-catenin signalling.
    Brain. 2019 Dec 31. pii: 5692272. doi: 10.1093.
    PubMed     Abstract available

    October 2019
  3. HERTING CJ, Chen Z, Maximov V, Duffy A, et al
    Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema.
    Brain. 2019 Oct 30. pii: 5610123. doi: 10.1093.
    PubMed     Abstract available

    August 2019
  4. YI GZ, Huang G, Guo M, Zhang X, et al
    Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2.
    Brain. 2019;142:2352-2366.
    PubMed     Abstract available

    April 2019
  5. BEHNAN J, Finocchiaro G, Hanna G
    The landscape of the mesenchymal signature in brain tumours.
    Brain. 2019;142:847-866.
    PubMed     Abstract available

  6. RECH F, Herbet G, Gaudeau Y, Mezieres S, et al
    A probabilistic map of negative motor areas of the upper limb and face: a brain stimulation study.
    Brain. 2019;142:952-965.
    PubMed     Abstract available

    April 2018
  7. NOTA NM, Wiepjes CM, de Blok CJM, Gooren LJG, et al
    The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment.
    Brain. 2018 Apr 23. pii: 4983052. doi: 10.1093.
    PubMed     Abstract available

    February 2018
  8. FERRUCCI V, de Antonellis P, Pennino FP, Asadzadeh F, et al
    Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-beta-OTX2-SNAIL via PTEN inhibition.
    Brain. 2018 Feb 27. pii: 4911167. doi: 10.1093.
    PubMed     Abstract available

  9. LUTTERS B, Koehler PJ
    Cerebral pneumography and the 20th century localization of brain tumours.
    Brain. 2018 Feb 6. pii: 4840595. doi: 10.1093.

    January 2018
  10. FONTAINE D, Almairac F, Santucci S, Fernandez C, et al
    Dural and pial pain-sensitive structures in humans: new inputs from awake craniotomies.
    Brain. 2018 Jan 29. pii: 4829675. doi: 10.1093.
    PubMed     Abstract available

    October 2017
  11. HARFORD-WRIGHT E, Andre-Gregoire G, Jacobs KA, Treps L, et al
    Pharmacological targeting of apelin impairs glioblastoma growth.
    Brain. 2017 Oct 3. doi: 10.1093.
    PubMed     Abstract available

  12. THIEPOLD AL, Lorenz NI, Foltyn M, Engel AL, et al
    Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death.
    Brain. 2017;140:2623-2638.
    PubMed     Abstract available

    April 2017
  13. PERRY A, Saunders SN, Stiso J, Dewar C, et al
    Effects of prefrontal cortex damage on emotion understanding: EEG and behavioural evidence.
    Brain. 2017;140:1086-1099.
    PubMed     Abstract available

    February 2017
  14. POON CC, Sarkar S, Yong VW, Kelly JJ, et al
    Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.
    Brain. 2017 Feb 4. doi: 10.1093.
    PubMed     Abstract available

    December 2016
  15. WELLER M, Holland EC, Hambardzumyan D
    Reply: Corticosteroids compromise survival in glioblastoma in part through their elevation of blood glucose levels.
    Brain. 2016 Dec 21. pii: aww325. doi: 10.1093.

  16. KLEMENT RJ, Champ CE
    Corticosteroids compromise survival in glioblastoma in part through their elevation of blood glucose levels.
    Brain. 2016 Dec 21. pii: aww324. doi: 10.1093.

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.